Investment
Features
FeesSafety
Academy
More
Pluang+

Compare SOLAI Limited (SLAI) vs 22nd Century Group Inc (XXII) Price & Performance

SOLAI LimitedTrade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

SOLAI Limited vs 22nd Century Group Inc — how do they compare? SOLAI Limited trades at $3.72 (market cap $16.69M), while 22nd Century Group Inc trades at $4.44 (market cap $1.52M). The key difference: SOLAI Limited is far larger — about 11× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.

SLAIXXII
Market Cap
$16.69M$1.52M
Sector
TechnologyTechnology
52-Week High
$26.74$801.00
52-Week Low
$2.74$3.72
Enterprise Value
$16.33M-$6.71M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SOLAI Limited

SLAI trades at $3.72 with no recent price movement, showing mixed technical signals despite a bullish overall rating. The company faces severe financial distress with negative profit margins (-134.63% net income margin) and declining revenue, compounded by NYSE delisting proceedings initiated in July 2026. Recent corporate actions include a 7:1 reverse stock split completed in July 2026 and the acquisition of a 51% stake in NEURALAND, signaling strategic shifts amid operational challenges.

The outlook remains highly speculative with significant execution and liquidity risks. While technical indicators suggest potential short-term momentum, fundamental weaknesses and delisting uncertainty create substantial downside risk. Investors should approach with caution given the company's negative profitability and regulatory challenges.

22nd Century Group Inc

22nd Century Group (XXII) trades at $4.31, down 0.92% on the day, with a neutral technical signal and bearish moving averages. The company shows deep unprofitability with a gross margin of -52.19% and net margin of -65.76%, though revenue was $7.05M in 2025. Recent corporate actions include a 20:1 reverse stock split in June 2026, and news highlights retail expansion for VLN reduced-nicotine cigarettes in California and New York.

The outlook remains speculative with high execution risk amid persistent losses, but analyst sentiment is bullish with 75% buy ratings. Key risks include negative cash flow from operations, regulatory hurdles for tobacco products, and the need for successful commercialization of VLN to achieve profitability.

Returns comparison

Trailing returns across standard periods

About SOLAI Limited

SOLAI focuses on providing innovative AI-driven software solutions. The company leverages artificial intelligence to enhance digital experiences and optimize business processes for various industries.

Read more on SLAI

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII